This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Idenix Pharmaceuticals Inc (IDIX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 122.01M 230.83M 118.27M 46.12M
Receivables 1.41M 1.20M 1.16M 840.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 4.94M 3.67M 4.00M 2.12M
Total Current Assets 129.75M 237.79M 123.84M 49.49M
Property, Plant & Equipment, Gross 15.62M 22.13M 21.57M 25.13M
Accumulated Depreciation & Depletion 12.84M 18.86M 16.87M 17.95M
Property, Plant & Equipment, Net 2.78M 3.27M 4.70M 7.18M
Intangibles 0.00 0.00 8.71M 9.84M
Other Non-Current Assets 8.48M 9.80M 3.80M 3.37M
Total Non-Current Assets 11.26M 13.07M 17.21M 20.39M
Liabilities & Shareholder Equity
Total Assets 141.01M 250.86M 141.04M 69.88M
Accounts Payable 7.78M 5.77M 2.89M 2.56M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 392.00K 868.00K 261.00K 305.00K
Total Current Liabilities 18.19M 15.93M 50.52M 19.99M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 16.82M 15.77M 39.29M 80.99M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 16.82M 15.77M 39.29M 80.99M
Total Liabilities 35.01M 31.70M 89.82M 100.98M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 106.00M 219.16M 51.22M -31.10M
Common Par 134.00K 134.00K 107.00K 73.00K
Additional Paid In Capital 935.41M 926.67M 726.47M 591.88M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -830.40M -708.12M -675.72M -623.74M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 859.00K 470.00K 365.00K 683.00K
Total Capitalization 106.00M 219.16M 51.22M -31.10M
Total Equity 106.00M 219.16M 51.22M -31.10M
Total Liabilities & Stock Equity 141.01M 250.86M 141.04M 69.88M
Total Common Shares Outstanding 134.12M 133.96M 107.22M 73.09M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 133.98M 118.76M 90.83M 70.72M
Diluted Weighted Shares Outstanding 133.98M 118.76M 90.83M 70.72M
Number of Employees 84 107 105 109
Number of Part-Time Employees 0 0 0 0

IDIX Idenix Pharmaceuticals Inc

Analysts Ratings for IDIX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 3 3
Moderate Buy 0 0 0 0
Hold 6 6 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 2 2

Brokerage Partners

IDIX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs